Safety Rates Drug Report: LAMIVUDINE. Hyperlipidaemia adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LAMIVUDINE. Injury: Hyperlipidaemia Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 14 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
126762491	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126763231	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126763721	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126763821	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126763831	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126764051	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160823	KR
126788281	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160824	KR
126788361	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160824	KR
126788431	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160824	KR
126788491	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160824	KR
126788541	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160824	KR
126828481	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160825	JP
126828531	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160825	JP
126872321	LAMIVUDINE.	Hyperlipidaemia	CIPLA	0.00		0	20160826	JP

|< 1/2 << Previous Page Page 1

Total Records: 14 Number of Pages: 1

Execution Time: 0.067698955535889 seconds (ucode:5030288). Developed by: James D. Barger